Latest Regulatory News

Pancontinental Energy has responded to an ASX query about recent spikes in its share price and trading volume, confirming no undisclosed information exists and pointing to strong industry interest in its PEL 87 project.

The Acting President of the Takeovers Panel has declined an interim order to postpone FBR Limited’s upcoming Extraordinary General Meeting, keeping the scheduled vote on track.

Magnum Mining & Exploration has completed its acquisition of Palmares Estudos Geologicos LTDA, securing a significant rare earths landholding in Brazil after an extended due diligence process.

Spenda Limited has responded to an ASX price query following a notable rise in its share price and trading volume, denying any undisclosed material information while confirming ongoing confidential negotiations for virtual card and funding services.

Finexia Financial Group announces the resignation of Interim CEO Marc Duncan as the Board intensifies its review of credit operations and pursues ASX securities reinstatement.

Pact Group Holdings has received conditional approval from the ASX for its voluntary delisting, pending shareholder endorsement at an upcoming extraordinary general meeting scheduled for 12 June 2025.

Citigold Corporation Limited has had its trading suspension lifted immediately following the submission of its reissued half year financial report and responses to ASX compliance queries.

Citigold Corporation Limited has faced intense ASX scrutiny following an adverse auditor opinion on its half-year financials, centering on a $20 million impairment of exploration assets. The company defends its valuation approach despite funding uncertainties and regulatory questions.

Bio-Gene Technology Limited is progressing its development of two novel insecticidal compounds, Qcide and Flavocide, targeting major global markets with strong commercial validation and significant US Department of Defense funding.

Anax Metals has locked in a $3.3 million convertible note investment from Mineral Development Partners, with conditional commitments for up to $100 million to advance the Whim Creek Project and establish a Pilbara base metals hub.

Neurotech International has reported excellent safety and tolerability for its lead drug NTI164 in 28-day GLP toxicology studies, paving the way for regulatory submissions and longer-term clinical development.

Bio-Gene Technology Limited has raised $2.1 million through a placement and launched a Share Purchase Plan to fund critical safety studies for its flagship insecticide Flavocide®, alongside development of Qcide and strategic initiatives.